AEQUITA PHARMACY: Drug Recall
Recall #D-0554-2025 · 07/18/2025
Class II: Risk
Recall Details
- Recall Number
- D-0554-2025
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- AEQUITA PHARMACY
- Status
- Ongoing
- Date Initiated
- 07/18/2025
- Location
- Kirkland, WA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 236 vials
Reason for Recall
Lack of Processing Controls.
Product Description
Tirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Distribution Pattern
MA
Other Recalls by AEQUITA PHARMACY
- Class II: Risk 07/18/2025
- Class II: Risk 07/18/2025
- Class II: Risk 07/18/2025
- Class II: Risk 07/18/2025
- Class II: Risk 07/18/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.